141 related articles for article (PubMed ID: 17169643)
21. Risk factors for lower urinary tract symptoms suggestive of benign prostatic hyperplasia in a community based population of healthy aging men: the Krimpen Study.
Kok ET; Schouten BW; Bohnen AM; Groeneveld FP; Thomas S; Bosch JL
J Urol; 2009 Feb; 181(2):710-6. PubMed ID: 19091352
[TBL] [Abstract][Full Text] [Related]
22. Urogenital history in veterans exposed to high-dose sulfur mustard: a preliminary study of self-reported data.
Soroush MR; Ghanei M; Assari S; Khoddami Vishteh HR
Urol J; 2009; 6(2):114-9; discussion 119. PubMed ID: 19472130
[TBL] [Abstract][Full Text] [Related]
23. Polymorphisms in genes involved in sex hormone metabolism may increase risk of benign prostatic hyperplasia.
Roberts RO; Bergstralh EJ; Farmer SA; Jacobson DJ; Hebbring SJ; Cunningham JM; Thibodeau SN; Lieber MM; Jacobsen SJ
Prostate; 2006 Mar; 66(4):392-404. PubMed ID: 16302261
[TBL] [Abstract][Full Text] [Related]
24. Metabolic syndrome components in relation to risk of cataract extraction: a prospective cohort study of women.
Lindblad BE; Håkansson N; Philipson B; Wolk A
Ophthalmology; 2008 Oct; 115(10):1687-92. PubMed ID: 18538408
[TBL] [Abstract][Full Text] [Related]
25. Complement C3 and C4 in plasma and incidence of myocardial infarction and stroke: a population-based cohort study.
Engström G; Hedblad B; Janzon L; Lindgärde F
Eur J Cardiovasc Prev Rehabil; 2007 Jun; 14(3):392-7. PubMed ID: 17568238
[TBL] [Abstract][Full Text] [Related]
26. Metabolic syndrome, its preeminent clusters, incident coronary heart disease and all-cause mortality--results of prospective analysis for the Atherosclerosis Risk in Communities study.
Hong Y; Jin X; Mo J; Lin HM; Duan Y; Pu M; Wolbrette DL; Liao D
J Intern Med; 2007 Jul; 262(1):113-22. PubMed ID: 17598819
[TBL] [Abstract][Full Text] [Related]
27. Trends in adverse events of benign prostatic hyperplasia (BPH) in the USA, 1998 to 2008.
Stroup SP; Palazzi-Churas K; Kopp RP; Parsons JK
BJU Int; 2012 Jan; 109(1):84-7. PubMed ID: 21615853
[TBL] [Abstract][Full Text] [Related]
28. The effect of middle-age body weight and physical activity on the risk of early revision hip arthroplasty: a cohort study of 1,535 individuals.
Flugsrud GB; Nordsletten L; Espehaug B; Havelin LI; Meyer HE
Acta Orthop; 2007 Feb; 78(1):99-107. PubMed ID: 17453400
[TBL] [Abstract][Full Text] [Related]
29. Race/ethnicity, obesity, health related behaviors and the risk of symptomatic benign prostatic hyperplasia: results from the prostate cancer prevention trial.
Kristal AR; Arnold KB; Schenk JM; Neuhouser ML; Weiss N; Goodman P; Antvelink CM; Penson DF; Thompson IM
J Urol; 2007 Apr; 177(4):1395-400; quiz 1591. PubMed ID: 17382740
[TBL] [Abstract][Full Text] [Related]
30. Anthropometric factors at age 20 years and risk of thyroid cancer.
Suzuki T; Matsuo K; Hasegawa Y; Hiraki A; Kawase T; Tanaka H; Tajima K
Cancer Causes Control; 2008 Dec; 19(10):1233-42. PubMed ID: 18618280
[TBL] [Abstract][Full Text] [Related]
31. Evaluating use patterns of and adherence to medications for benign prostatic hyperplasia.
Nichol MB; Knight TK; Wu J; Barron R; Penson DF
J Urol; 2009 May; 181(5):2214-21; discussion 2221-2. PubMed ID: 19296986
[TBL] [Abstract][Full Text] [Related]
32. Associations between serum lipids and causes of mortality in a cohort of 3,499 urban Thais: The Electricity Generating Authority of Thailand (EGAT) study.
Sritara P; Patoomanunt P; Woodward M; Narksawat K; Tulyadachanon S; Ratanachaiwong W; Sritara C; Barzi F; Yamwong S; Tanomsup S
Angiology; 2007 Dec-2008 Jan; 58(6):757-63. PubMed ID: 18216384
[TBL] [Abstract][Full Text] [Related]
33. Effects of selenium status, dietary glucosinolate intake and serum glutathione S-transferase α activity on the risk of benign prostatic hyperplasia.
Eichholzer M; Steinbrecher A; Kaaks R; Teucher B; Linseisen J; Rohrmann S
BJU Int; 2012 Dec; 110(11 Pt C):E879-85. PubMed ID: 22882569
[TBL] [Abstract][Full Text] [Related]
34. Prehypertension, obesity, and risk of kidney disease: 20-year follow-up of the HUNT I study in Norway.
Munkhaugen J; Lydersen S; Widerøe TE; Hallan S
Am J Kidney Dis; 2009 Oct; 54(4):638-46. PubMed ID: 19515474
[TBL] [Abstract][Full Text] [Related]
35. Normal fasting plasma glucose and risk of type 2 diabetes diagnosis.
Nichols GA; Hillier TA; Brown JB
Am J Med; 2008 Jun; 121(6):519-24. PubMed ID: 18501234
[TBL] [Abstract][Full Text] [Related]
36. Thyroid hormone use, hyperthyroidism and mortality in older women.
Bauer DC; Rodondi N; Stone KL; Hillier TA; ;
Am J Med; 2007 Apr; 120(4):343-9. PubMed ID: 17398229
[TBL] [Abstract][Full Text] [Related]
37. A prospective study of dairy consumption in relation to changes in metabolic risk factors: the Hoorn Study.
Snijder MB; van Dam RM; Stehouwer CD; Hiddink GJ; Heine RJ; Dekker JM
Obesity (Silver Spring); 2008 Mar; 16(3):706-9. PubMed ID: 18239556
[TBL] [Abstract][Full Text] [Related]
38. Variability and risk factors for kidney disease progression and death following attainment of stage 4 CKD in a referred cohort.
Levin A; Djurdjev O; Beaulieu M; Er L
Am J Kidney Dis; 2008 Oct; 52(4):661-71. PubMed ID: 18805347
[TBL] [Abstract][Full Text] [Related]
39. Regular egg consumption does not increase the risk of stroke and cardiovascular diseases.
Qureshi AI; Suri FK; Ahmed S; Nasar A; Divani AA; Kirmani JF
Med Sci Monit; 2007 Jan; 13(1):CR1-8. PubMed ID: 17179903
[TBL] [Abstract][Full Text] [Related]
40. Dietary patterns and surgically treated benign prostatic hyperplasia: a case control study in Western Australia.
Ambrosini GL; de Klerk NH; Mackerras D; Leavy J; Fritschi L
BJU Int; 2008 Apr; 101(7):853-60. PubMed ID: 18070188
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
